N
Google TrendANNA BONDAR (200+) — October 12, 2026: Tommy Paul vs Valentin Vacherot: Set 2 Winner Tennis Prediction Market
The 24/7 Global Portal

World News, Markets & Google Trends

Aggregated real-time headlines, trending Google search queries, and verified dispatches in one single page.

Google Trends:anna bondar200+natanael cano100+green card500+power outage near me10000+india2000+sony playstation1000+loki100+hubert hurkacz200+
Category:All HeadlinesWorld & GeopoliticsMarkets & EconomyTech & AIPoliticsSearch results for: "Achieving Clinical Remiss" (30 stories)

Top Headline Story

Triple Inhaler Therapy May Edge Out Dual Therapy for Clinical Remission in Uncontrolled Moderate-to-Severe Asthma
Lead StoryMedscapeworld
Sep 29

Triple Inhaler Therapy May Edge Out Dual Therapy for Clinical Remission in Uncontrolled Moderate-to-Severe Asthma

<a href="https://news.google.com/rss/articles/CBMiqwFBVV95cUxPMmtwaE9TWG5iQjI2dFZaYkNnY05hVFptZ1otQ2IxVEVoZ1Z1WV9NNjhUUzJBdjRsOTVEcVppTWxaZE5tMzhya2c3ZkxpQTk4RUV1MC1tei1fWEc3enNRQXp0MnpZaE1kMFVpM1NkTDZ6RmoxQmVrZVBaUy1rNVNKeVB4VElmTmZyeE81Yko4MHJrX2VBVS1kTGxLNnZ6a3pnZGhiR2gydmdXV0U?oc=5" target="_blank">Triple Inhaler Therapy May Edge Out Dual Therapy for Clinical Remission in Uncontrolled Moderate-to-Severe Asthma</a>  <font color="#6f6f6f">Medscape</font>

Read Full StoryRelated Trends

Google Trends & Trending Search Intelligence

Real-time search volume
200+19m ago

anna bondar

October 12, 2026: Tommy Paul vs Valentin Vacherot: Set 2 Winner Tennis Prediction Market

Filter stories
100+19m ago

natanael cano

Padres de Natanael Cano rompen el silencio tras retiro del cantante: "Es por el bien de nuestro hijo"

Filter stories
500+29m ago

green card

Vance says Microsoft replaced laid-off workers with foreign hires. Here’s what the visa data shows

Filter stories
10000+29m ago

power outage near me

LIVE | Atlanta weather: Power outages, tree damage remain as storm threat moves east

Filter stories

Search Results for "Achieving Clinical Remiss"

Updated every 3 minutes via FreeNewsApi, GNews, Currents API & Google News

29 stories displayed
Obefazimod Delivers Week 44 Remission in Refractory UC Patients
HCPLivegeneral

Obefazimod Delivers Week 44 Remission in Refractory UC Patients

<a href="https://news.google.com/rss/articles/CBMilwFBVV95cUxNVXBoYjVEc0ctbzZaZzFIUHJkc2VqT2lYSk05T2lUMVA1S2c5b3loWHFRclIzQlVkYWM0ZGpnc3Q5cm0zdFBoV095alBVMDc4RFNJNnBFUjMtZ3BpX3hmTmxUeUc5NFYwRV96YldtM01rOWZSc0hEUWc2YXByMk51b2hUSzEwSVBGY0dXWnB5VkhiQ0FRaUd3?oc=5" target="_blank">Obefazimod Delivers Week 44 Remission in Refractory UC Patients</a>  <font color="#6f6f6f">HCPLive</font>

Read Full StoryMore like this
Gastroenterologists flag clinical remission and its durability as unmet needs in IBD care: survey
Fierce Pharmaworld

Gastroenterologists flag clinical remission and its durability as unmet needs in IBD care: survey

<a href="https://news.google.com/rss/articles/CBMiwgFBVV95cUxQYXh0dDlKQjB3WmVlVU5EcVBiUW1ySmwyd2JsQnlFVkM3WnJzdmdDRmhZMUIxVmt1eEZUZjdta3RxZXhQamFQSTNwZHdHTjFWWG55M0xGT3NKRlNEUndObHFyWXBkdkNFY3NMbVAtWlZmWE1yTkUyaUdhVEN0SGVKN1lzcDBNWkN5R0cyZUh0RnJEOC1abXN1eDlCZUllTmlkcTVKVnV4YTRFTTFYYXdaUW0zakZUVm1scm1MWGtkVzNUQQ?oc=5" target="_blank">Gastroenterologists flag clinical remission and its durability as unmet needs in IBD care: survey</a>  <font color="#6f6f6f">Fierce Pharma</font>

Read Full StoryMore like this
Benralizumab Achieves Clinical Remission in Severe Asthma
European Medical Journalgeneral

Benralizumab Achieves Clinical Remission in Severe Asthma

<a href="https://news.google.com/rss/articles/CBMipAFBVV95cUxNbWpSNVVzZVJUMWRBQ2dNUzFyUDZmNTZkc19wSmlTNmxMT3FRSXJJUmF5cUtfSnBRSkZNQnlxajlFMWdoMm91NGtCRlVXbHhyRExtdTZYM2tFRW4wYXNRXzJPa2JkZ09RYU85ZUxXa1pLcXJEY3VuRGctZEZQQllmMDJIY1FlSEl3U0xzMVRKa2djaDlybC1Pc2o0WHVWNEJZX2Q4VQ?oc=5" target="_blank">Benralizumab Achieves Clinical Remission in Severe Asthma</a>  <font color="#6f6f6f">European Medical Journal</font>

Read Full StoryMore like this
Upadacitinib for Refractory IBD | Gastro Today
DocWireNewsgeneral

Upadacitinib for Refractory IBD | Gastro Today

<a href="https://news.google.com/rss/articles/CBMizAFBVV95cUxOc2ZTTXhpVDBlTS1LenNoN0ZzNGpmWEhsbDhMOEFJVTllQXJ3eTJwNXFNQ0dDdlNwTkQ3UVFwcFhOV3o3eTRCX2hnMEFnbGhxZlpUcjlmRWhxa3JoNWVScUZkY1p4QmdPZnMwOWszVDNfRzF1dnY0LUN5WHdjd2tjeExxMUpJY0JubjlWNEdYWUw1ZlFkQzEyVWxkRk1jalN2UWlQTkpDc2tteGhySEVhQjRmZS1MWUJQbXNORnRKSG5VMUp2QTFGT0VVenQ?oc=5" target="_blank">Upadacitinib for Refractory IBD | Gastro Today</a>  <font color="#6f6f6f">DocWireNews</font>

Read Full StoryMore like this
Upadacitinib Delivers Durable 1-Year Benefits in Real-World UC
MedPage Todayworld

Upadacitinib Delivers Durable 1-Year Benefits in Real-World UC

<a href="https://news.google.com/rss/articles/CBMiZkFVX3lxTFB3TXF3XzM4alNwM09ZTDVKTlJKNTNpZTc1Y3Nvbm1GLVNiT1JKcTVSSHJWemFrTkN4TklpSHJOdEphaTNmYzlKVG0zN3F4dEFLcTVib2wwbnZqNldqWVhXNXJFZG1xQQ?oc=5" target="_blank">Upadacitinib Delivers Durable 1-Year Benefits in Real-World UC</a>  <font color="#6f6f6f">MedPage Today</font>

Read Full StoryMore like this
TL1A Antibody Duvakitug Boosts Clinical Remission in UC, Response in CD
HCPLivegeneral

TL1A Antibody Duvakitug Boosts Clinical Remission in UC, Response in CD

<a href="https://news.google.com/rss/articles/CBMioAFBVV95cUxNbi1zN0ZmQW5hUDZ3SGJwWkxBbnk5SWN3TE1zVEdHR2Z2SmxEaC1iTnlhNkZ0dHhoUFU4czNEcjgtRjdrRjl4cC0wUUJINy11anNxenQtX2ItTTFWd0Q0VWlfYXZLVU5NN0hXQnFTMGQzeHBIeWxwNG8tRUdOXzUtNTFIZXJOTTF3RVpubVNXY2h1bWlRdHRSWlZObEF0QWxf?oc=5" target="_blank">TL1A Antibody Duvakitug Boosts Clinical Remission in UC, Response in CD</a>  <font color="#6f6f6f">HCPLive</font>

Read Full StoryMore like this
Beyond Symptom Management: The Critical Value of Remission in Dermatologic Care
Medscapegeneral

Beyond Symptom Management: The Critical Value of Remission in Dermatologic Care

<a href="https://news.google.com/rss/articles/CBMiogFBVV95cUxORTE4ZjZ0aXlPeGxWTEl5ZzZIa3ZWeE5nRjU5OTJMcWdSU1Q0bTZ0ZlBIQmF5a1NMOUZ3Nm5ndWFrSHg1SUl5T3JscU8teW1MVk9nMy1kVVlZZkFUWG5KTXU1a1UzMjlqa0xZdWl5U0o2R2NndkRGZ3RiQnU3RmY4VG5lbi0ySTJkazBTekN6dGx2amc5NHpYSC1mN0pGdndLRXc?oc=5" target="_blank">Beyond Symptom Management: The Critical Value of Remission in Dermatologic Care</a>  <font color="#6f6f6f">Medscape</font>

Read Full StoryMore like this
Tulisokibart Shows Superior Efficacy in Achieving Clinical Remission for Ulcerative Colitis Patients
Applied Clinical Trials Onlinegeneral

Tulisokibart Shows Superior Efficacy in Achieving Clinical Remission for Ulcerative Colitis Patients

<a href="https://news.google.com/rss/articles/CBMiuAFBVV95cUxNSVRWYTNKUlVwbThxbVJwTmlsQUFDV01NakJ5SWZpcGhsbnZxUzZVbmFiXzViMGxpeng5LVBXOXp5RXVLbnM4Q2RIQnB0MmtBNDE5WS1nWXF1cUUwZ2laaFpjTGhLal9GN19vQ3p5aWNwNjdxQzRPUlNpOFpsU2I1d04xSThqajVPVnBZd202b3hjTllXR0I3anltQkdreXd1REZIQTNmYTgzWVBVTUdaM1JMcWhUaHdr?oc=5" target="_blank">Tulisokibart Shows Superior Efficacy in Achieving Clinical Remission for Ulcerative Colitis Patients</a>  <font color="#6f6f6f">Applied Clinical Trials Online</font>

Read Full StoryMore like this
Final U-ACHIEVE analysis: Upadacitinib well-tolerated, maintains clinical remission in UC
Healiotech

Final U-ACHIEVE analysis: Upadacitinib well-tolerated, maintains clinical remission in UC

<a href="https://news.google.com/rss/articles/CBMi1gFBVV95cUxOaG5DN2FKcVpROVBjMFljbkZ3U3NGUGlQSU13NmtYSnlNZTE5UElvbHBQODBaY1otSmVwcDFoRWNyUG9Vdno4U2FreVNhREItbkFSQ0VENExFSmM3aDJRX01Odmt5X1RXWlZGdlZURDJHUWNEREg5aHVZOFd3WU1mN1FHQl8xNkZzZXI3LWNCX3RXU0xpWGNjMUJ1eDdSb2VtQ2NJR2tORzgwVmxCVmJ3UzhSRUV5M1pGTTdZdTFJZGRRcnRFUGdKREs3VWdjY3kya0d3LTRR?oc=5" target="_blank">Final U-ACHIEVE analysis: Upadacitinib well-tolerated, maintains clinical remission in UC</a>  <font color="#6f6f6f">Healio</font>

Read Full StoryMore like this
Dupilumab Nearly Doubled Remission Odds in Type 2 Asthma, With Simon Couillard, MD
HCPLivegeneral

Dupilumab Nearly Doubled Remission Odds in Type 2 Asthma, With Simon Couillard, MD

<a href="https://news.google.com/rss/articles/CBMimgFBVV95cUxOcHpVU0d5QkpsUHB6LVQ4N0xxeFd6VFJXVTlOQWpmRHJJMTBFVXhvRE55MU5oTHg0V3JjTEdZYXkyQUJLUllNNWF2MFNvRzNBNmFjeGNqMUlhUmJBMnVkM3JKd3FBdFlLY1huQmV1cUVqRlNxVW8xY0tNbTFtWG5SVEhfVHBXOTlXcV9YdWdfaUdxb241LUtYQzJ3?oc=5" target="_blank">Dupilumab Nearly Doubled Remission Odds in Type 2 Asthma, With Simon Couillard, MD</a>  <font color="#6f6f6f">HCPLive</font>

Read Full StoryMore like this
Lilly's Mirikizumab Helped Patients with Crohn's Disease Achieve Long-Term Remission in Phase 3 Trial
PR Newswiregeneral

Lilly's Mirikizumab Helped Patients with Crohn's Disease Achieve Long-Term Remission in Phase 3 Trial

<a href="https://news.google.com/rss/articles/CBMi6wFBVV95cUxNamxpQmVaTGVLcksyd25CZlNUNkdLWk42Z0hLOFFYVEhYa1VGYWhrQTRtbjk4bGpjbktTQjdBbDNxcTJJcVhsNlQyaVJ0UlRHRWNLanBUYVFFMklSTmZkTlAyWEZtOGVsX0JScWtBbWVDRXlDV1Z3Qm9VdTY2emRUbEVlOVlLbHpHNzg0akxHWjZHWXVpWk1GTmRJX3NXaTVlOEhTek9lek03NGljb3gwdTJ1TTdyWi00dmpYOE9IcFktaUs0dTdiRkNubS0zRUZ3dEVqYmE5cWNGTlh5UEJDZm9vdDNRcGl0clBr?oc=5" target="_blank">Lilly's Mirikizumab Helped Patients with Crohn's Disease Achieve Long-Term Remission in Phase 3 Trial</a>  <font color="#6f6f6f">PR Newswire</font>

Read Full StoryMore like this
Study: Crohn’s Disease Investigational Treatment Shows Potential for Achieving Remission
Cedars-Sinaigeneral

Study: Crohn’s Disease Investigational Treatment Shows Potential for Achieving Remission

<a href="https://news.google.com/rss/articles/CBMiwwFBVV95cUxNSVdxMlFzUmM1bzlFbTVjbzhKWloxb2F6NVdEN29vNUpaaFRMbjh0a3F4V2Y5UlRja1hjVmVTQXBEZEhvVl9naW0xREpyMUtDQzQ0SUF5YVlsVmFYVjdmcXhUZm5IRVdVMWkzRVJXM2wxSXJhblJtLVl6ejZOSjVQUno4RDltcHdYeDloMEpLbldDZDgyRkNjWGFyem1HVnh6ZlZiWk9mV1gtT3FlT0loRFI3NndReVdfdXVVQ3ItZ3Y5QlU?oc=5" target="_blank">Study: Crohn’s Disease Investigational Treatment Shows Potential for Achieving Remission</a>  <font color="#6f6f6f">Cedars-Sinai</font>

Read Full StoryMore like this
Respirology | APSR Respiratory Medicine Journal
Wiley Online Librarygeneral

Respirology | APSR Respiratory Medicine Journal

<a href="https://news.google.com/rss/articles/CBMiZEFVX3lxTFBfaXhUYlh4VmxoY1JwM2V4eDBjRG9nb1RLUm1oYV81NHdsbkpDUUVOQWhydUdfdWx2UXpYckUwQjNTR2toaWNuQ3lYWVV6Um9zeFJGUkhRRlRpWTdSOEtaMl9SeHM?oc=5" target="_blank">Respirology | APSR Respiratory Medicine Journal</a>  <font color="#6f6f6f">Wiley Online Library</font>

Read Full StoryMore like this
Is diabetes remission really as hard to achieve as a new study suggests?
The Conversationgeneral

Is diabetes remission really as hard to achieve as a new study suggests?

<a href="https://news.google.com/rss/articles/CBMiqgFBVV95cUxQWnlYUGxJSlJqcnlBTk9vWDNNOVc2ODdEajl4T2FtYVNsdWJGa0h6dWtsUktSbWpJOG9IbnZKSkVVZUR5a3pHZU9LQTVkRlNYQ1pXN1ZzVmtWYllJVDctSXY5M0lXYmRCMFJCRnhRYUcyNVRkVmNia1hyU2FKM0d4Zm9mYUJORGdFNUJldFotQ2ZXLWo0VU5LYThzSl9rQzNvcUotY0lYVmZ1dw?oc=5" target="_blank">Is diabetes remission really as hard to achieve as a new study suggests?</a>  <font color="#6f6f6f">The Conversation</font>

Read Full StoryMore like this
Fifty Percent of Patients with Ulcerative Colitis Treated with Mirikizumab Achieved Clinical Remission at One Year in Lilly's Pivotal Phase 3 Study
Eli Lillygeneral

Fifty Percent of Patients with Ulcerative Colitis Treated with Mirikizumab Achieved Clinical Remission at One Year in Lilly's Pivotal Phase 3 Study

<a href="https://news.google.com/rss/articles/CBMiwAFBVV95cUxNX1RkM0xjaWEzV2hLUC1mbzhMUkZ3Z0ttUUVIeGwtWjlIUGFkYm9MeEVXN0tCUnExT3B2aTFNVU1TQkF3OHRYUkdDNmp0eGlRdXA5eVhhdEZ1UWs5M2pNY2FtODJJTENaZ2VCck5WbEJPMUZNLWN3NDUxQS1NeHA0ZXVPeXJ5V0tQWFZuVmdLNXRpTTh3a1hFRTgyZW9qRkh1cUdLTzIwTkl3OTZ3QXZtdTJaRmRkelV2N2JDRW1paHY?oc=5" target="_blank">Fifty Percent of Patients with Ulcerative Colitis Treated with Mirikizumab Achieved Clinical Remission at One Year in Lilly's Pivotal Phase 3 Study</a>  <font color="#6f6f6f">Eli Lilly</font>

Read Full StoryMore like this
Obefazimod Achieves Clinical Remission in Phase III Ulcerative Colitis Trials
Applied Clinical Trialsgeneral

Obefazimod Achieves Clinical Remission in Phase III Ulcerative Colitis Trials

<a href="https://news.google.com/rss/articles/CBMiwAFBVV95cUxPQnFVWlpqbjlHRlFXaW1CcmI1djlPSkNOQ1AwWE9vS19pRzU0cUQtOUM0Q2w3WERtTzI0NVRJQ2QwNlEwSVprVTlyaENjR2pGYU94aGNDNXZzOFk3bHZDWGdDSTZkdXlMMTJFNEN5czVLa3hPZUU1MVcyY2IxM1BhWmY5T2o2N0M0eEhNNUEyZHJURElWSzVSRE1hWEdiT2VEWkRqc2ZoM3ZkZlM5aU9TV2E5MWhrelFieVhvZElKdDY?oc=5" target="_blank">Obefazimod Achieves Clinical Remission in Phase III Ulcerative Colitis Trials</a>  <font color="#6f6f6f">Applied Clinical Trials</font>

Read Full StoryMore like this
Advancing Remission in Severe Asthma With Benralizumab: Latest Findings, Current Perspectives and Future Direction
Wiley Online Librarygeneral

Advancing Remission in Severe Asthma With Benralizumab: Latest Findings, Current Perspectives and Future Direction

<a href="https://news.google.com/rss/articles/CBMiakFVX3lxTE51c0dROGxnN3M1NGU1Q1lJV055MEJsSS1qZVByNmMwVnBIQXJFVkpsWjJ6UW9SZkhwYmlUWGxBX3lxX21nelRMZDdRRnE4dUxjUTlwbkE0NW5UcUZPMWxBdUIyQkhUbzE4V2c?oc=5" target="_blank">Advancing Remission in Severe Asthma With Benralizumab: Latest Findings, Current Perspectives and Future Direction</a>  <font color="#6f6f6f">Wiley Online Library</font>

Read Full StoryMore like this
Achieving Clinical Remission in Asthma Care, With Linda Rogers, MD
HCPLivegeneral

Achieving Clinical Remission in Asthma Care, With Linda Rogers, MD

<a href="https://news.google.com/rss/articles/CBMijgFBVV95cUxOZnhLamxLV2hHdHBzclNGRUlDeHhZVWJlX2pIWEdKNHFzOFg4RGVUM0t3T1Z3V19DNkZmYUhIbDR1RUJqRkc1ODJFdGNndURZb09NR3Q0dVN5OExoY3o1YjR5QUhlZHJDenRpbGRKMVdKQ2t3M3k4bFRldkkxc2MzZ3RESEtxaVRIYlJMeVBR?oc=5" target="_blank">Achieving Clinical Remission in Asthma Care, With Linda Rogers, MD</a>  <font color="#6f6f6f">HCPLive</font>

Read Full StoryMore like this
Patients With IBD Achieving Clinical Remission More Likely to Maintain Clinical Remission at 1 Year
HCPLivetech

Patients With IBD Achieving Clinical Remission More Likely to Maintain Clinical Remission at 1 Year

<a href="https://news.google.com/rss/articles/CBMixwFBVV95cUxPaURHWGp5QTV5bG9GZ0dKRDdpWnAxLUxzWE5nYVVuUDNBelhqeWRkWXBDb182bmw5b0Y3enJScUVsMENmVldPX3IxYUdmQUMxVk1mc3BjTFpqdVJSaF9RUkxtVjRlNDIxU3NROUdvYnhYdHFhemtKbFdkR09fUTJxUWUxa0R3VnhsQnVTZlMtWlVfZnJfOGV2aXpjSnlCRFJYaHk5SDltZTlTWWtBc3pvd2hsZW9jMlpaeW81VllkTjBWckJkbnBv?oc=5" target="_blank">Patients With IBD Achieving Clinical Remission More Likely to Maintain Clinical Remission at 1 Year</a>  <font color="#6f6f6f">HCPLive</font>

Read Full StoryMore like this
Upadacitinib Achieves 52% Clinical Remission in Crohn's
Physician's Weeklygeneral

Upadacitinib Achieves 52% Clinical Remission in Crohn's

<a href="https://news.google.com/rss/articles/CBMioAFBVV95cUxQbGNYMmhTb2NtRXJQcVcyVk1mUUluWFN2N2M4cm12YW44X0dYcEJpcW1lT3FrcGdQNTZyYnJvVi1pSC1PZlNRbEhzc1pmajNOS0NMVnlRZy1kSW8zT0RKQXk0RTRURGFDczBWdC16eG12YndCVjEydjYtMW5Jd3BRMXhuQTY1Zkh4Vk9ONjlnNUZVWUhtRmFHeXowT1hEeXFI?oc=5" target="_blank">Upadacitinib Achieves 52% Clinical Remission in Crohn's</a>  <font color="#6f6f6f">Physician's Weekly</font>

Read Full StoryMore like this
Clinical and Biological Remission With Tezepelumab: The Real-World Response in Severe Uncontrolled Asthma
Wiley Online Libraryworld

Clinical and Biological Remission With Tezepelumab: The Real-World Response in Severe Uncontrolled Asthma

<a href="https://news.google.com/rss/articles/CBMiakFVX3lxTE9INHFiX0NsQ0RscWxyQXlDc09MbnptMUg3S3ZURlNxUUNKSE5KSDBRbXRyQjJfczZnZjhwQ2htdGFzck5MaVVGWExrMkY3d2dtOS1RMGRyUXhNTGFrY0lfcHFfOUdxQ2JrT0E?oc=5" target="_blank">Clinical and Biological Remission With Tezepelumab: The Real-World Response in Severe Uncontrolled Asthma</a>  <font color="#6f6f6f">Wiley Online Library</font>

Read Full StoryMore like this
Diabetes Remission Is Possible, but There’s Not Just One Way
Medscapegeneral

Diabetes Remission Is Possible, but There’s Not Just One Way

<a href="https://news.google.com/rss/articles/CBMiowFBVV95cUxPeWNqd3RGcDdhTmVpaTllTWJvUmlod09QUzN6b21vVUJTSmlndzRNdU84eU00VDhJTEI0dkhPWkd3RnlXdVMyMUd3TElsV1YwNWNFZHl6VEpHdXlVaGlKNUtWVnJHYlRCdnNUbFlJd1hmUUVpa01DNkZoOWVyd0hCekxzZHZVbUZ0OGRSM3d1WmdwOXZFck1FQmtuVXJCejVRd3hN?oc=5" target="_blank">Diabetes Remission Is Possible, but There’s Not Just One Way</a>  <font color="#6f6f6f">Medscape</font>

Read Full StoryMore like this
Achieving drug-free remission in axial spondyloarthritis: Exploring the role of tight control in early disease
Medical Xpressgeneral

Achieving drug-free remission in axial spondyloarthritis: Exploring the role of tight control in early disease

<a href="https://news.google.com/rss/articles/CBMikAFBVV95cUxNTktpR1RVbVE4Y3ctaTU4dG1BcU0yQ1dOQTB6Qm1HYU5WcTBxeHQ5VklDMkF1NHFzYUtlS3VpT3YxWFN0bUJxYlctcUwtZk9OYUozYzAzVDh5dmxseUh6cUJUemFnTWlTUGVqZm9EdkN1OWlKbm1aYnMzVllnMWJfN3VZb1UxN2Q0MHV4UDhJRjI?oc=5" target="_blank">Achieving drug-free remission in axial spondyloarthritis: Exploring the role of tight control in early disease</a>  <font color="#6f6f6f">Medical Xpress</font>

Read Full StoryMore like this
Repetitive administration of rituximab can achieve and maintain clinical remission in patients with MCD or FSGS
Naturetech

Repetitive administration of rituximab can achieve and maintain clinical remission in patients with MCD or FSGS

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE1vbllaUjRENUZvcC1HVnRfVGFwRVg4clIzVUVKMWdCdU5uaER4Y0VWRUd6TFBuUjFFbjdGRm56NXRsak5xT3FabWw5cjk4LXpRNTYzN0hMV0RqZzM5anJr?oc=5" target="_blank">Repetitive administration of rituximab can achieve and maintain clinical remission in patients with MCD or FSGS</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Mepolizumab Achieves, Maintains Clinical Remission in Severe Eosinophilic Asthma Over 24 Months
Physician's Weeklytech

Mepolizumab Achieves, Maintains Clinical Remission in Severe Eosinophilic Asthma Over 24 Months

<a href="https://news.google.com/rss/articles/CBMixwFBVV95cUxOR2RIM3lYbUMtZEtMMGJSbE5IN3JUbC16eEcwS3FjbGdKVURVaVdQRzEtQmZKTU1GNFpEQnQwdU1jV2pZT2RrNXA0TUFzS3d0YU54V1dVdU1ycnJpUjhBYkNvMEZkSk81SDFtcC1UYlRkZkRYUHNSODlScEpRTjAtaXlKajk1SHplSXVYZUt5eG9pS0NCT2Y4anE4blVfcGswbzNZaHh4UWZhSmFjOVNrWWhpS01jcVpGV2h0aFlRcG5YNl81VzU4?oc=5" target="_blank">Mepolizumab Achieves, Maintains Clinical Remission in Severe Eosinophilic Asthma Over 24 Months</a>  <font color="#6f6f6f">Physician's Weekly</font>

Read Full StoryMore like this
COMMAND: Skyrizi outperforms placebo in achieving, maintaining clinical remission in UC
Healiotech

COMMAND: Skyrizi outperforms placebo in achieving, maintaining clinical remission in UC

<a href="https://news.google.com/rss/articles/CBMi1gFBVV95cUxNSjhvTjRBZ3YyTjd3TlRoMVRXTm1aajBIMWxZSXI5aDVMaGxab25MWHFMMDdnajc2NU83UUN6VzdpUVVjUkVFaHpnV04zOW9rQ0szOUJHZTBtUVlXemgtUDlNaDZCaF9acWc1Nk55R1ZCWGxoMm11QnU1X29XS1FsOERVSDktYzV2d3FKM3VyRHI1UWw3clE4YlZRTGo5YmJRQmI0Uk11T0NuNWVrakpRVDZjbG8wZ2ljNVBnNEVwT0l1cmZiMVZ1R0FGbngxSDZnb3RQbTNn?oc=5" target="_blank">COMMAND: Skyrizi outperforms placebo in achieving, maintaining clinical remission in UC</a>  <font color="#6f6f6f">Healio</font>

Read Full StoryMore like this
New Prediction Model Identifies Ocular Myasthenia Gravis Patients Likely to Achieve Remission
Review of Optometrygeneral

New Prediction Model Identifies Ocular Myasthenia Gravis Patients Likely to Achieve Remission

<a href="https://news.google.com/rss/articles/CBMi0AFBVV95cUxPY3M4ekNHbHBHS1BFcXUwNjR5dUNCQmlGY3ltT0hsWm43bldZeV93QnEzMU02VEo0bmpOOHdfb002Tk1UOTR3UElveDRodDFRY0xCRFV3UTFhLUZlQ2hGNnlqZy01R1BESnU0M3p2TC1PekhTQnVZc3ZfY2VmaVRHZzMyOXRCdzZwSFpqM0ltM3NaV3NXSFBabGJpUkpONVdGVjdwSjBaLXFJR1lQa0VkdTYtbVNHTERsbmx4UF9sTmgxWU5qNWxkVWlCU0lxcDR6?oc=5" target="_blank">New Prediction Model Identifies Ocular Myasthenia Gravis Patients Likely to Achieve Remission</a>  <font color="#6f6f6f">Review of Optometry</font>

Read Full StoryMore like this
Tremfya Achieves Significant Clinical Remission, Endoscopic Response in Moderate to Severe Crohn Disease at 48 Weeks
Applied Clinical Trialsgeneral

Tremfya Achieves Significant Clinical Remission, Endoscopic Response in Moderate to Severe Crohn Disease at 48 Weeks

<a href="https://news.google.com/rss/articles/CBMirgFBVV95cUxNMGpveTJEbXBKNlAtVUU3WEhBT01lQS1fRDYwUmZSSnlEU3dJS3pldGNBNVhHY2pkczFZSkdQczdBdy1scm8wZnk4RGZyRm85RmZGbHJDT08wcEhPRWVxLVp4Rjk4N0Nyckp6Y1BqZGlNZTJEVDV6T0FESW1zODByM3VPNGdBOG9IS2hqaFlwYzFWQ3VHSzY0Qk5sQy1OY29hamdHaUJxYkY0bVBCcUE?oc=5" target="_blank">Tremfya Achieves Significant Clinical Remission, Endoscopic Response in Moderate to Severe Crohn Disease at 48 Weeks</a>  <font color="#6f6f6f">Applied Clinical Trials</font>

Read Full StoryMore like this
Off-Treatment Remission Achieved with Dupilumab for Pediatric AD
Dermatology Timesgeneral

Off-Treatment Remission Achieved with Dupilumab for Pediatric AD

<a href="https://news.google.com/rss/articles/CBMipAFBVV95cUxNT0JIWk1MNS1pTzdfS0Y5RGJGQjlfa0Y3MmpVSWJlNmhKMGpzdUVxMWpkb1FCbWh5Rzg3d3RnR2dsQ3llandXejRsWFdiQ2ExV0Rta1hGcFVqM3Y4M1FFS3hhVUZuYU8tc3FjamlBaTNETWNCMkVqdTFGUm1xVGVPQy15M0NtS1ZUNENfaFV3UUsxZ2p2SHgzanUzUThkT21vbEZ1RQ?oc=5" target="_blank">Off-Treatment Remission Achieved with Dupilumab for Pediatric AD</a>  <font color="#6f6f6f">Dermatology Times</font>

Read Full StoryMore like this
"Achieving Clinical Remiss" — Live Google News Trends & Headlines